EVA Pharma
Cairo, Egypt· Est.
Egypt’s top pharma firm, EVA Pharma, combines large‑scale manufacturing with R&D to deliver diverse medicines across Africa.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Egypt’s top pharma firm, EVA Pharma, combines large‑scale manufacturing with R&D to deliver diverse medicines across Africa.
OncologyNeuroscienceRespiratoryCardiometabolic MedicineAnti‑infectivesOphthalmologyBone HealthPain ManagementHepatologySlimming and Well‑beingSexual and Reproductive Health
Technology Platform
EVA Pharma’s platform combines GMP‑certified solid‑dose and sterile manufacturing lines with advanced aseptic fill‑finish capabilities for biologics, supported by two research centers that enable formulation innovation and early‑stage drug discovery.
Opportunities
Scaling biologics manufacturing for African markets and expanding specialty partnerships can drive revenue growth and diversify the portfolio.
Risk Factors
Regulatory compliance across multiple jurisdictions and competition from multinational generics manufacturers pose significant challenges.
Competitive Landscape
EVA Pharma competes with regional giants such as Pharco and Amoun as well as global generics firms; its integrated manufacturing and partnership model offers a differentiated cost‑advantage.